The DOI matches its Crossref record; 251 of the 251 references it cites were found in a registry or an index.
American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Treatment of Tuberculosis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.4.16141 · Cited by 1,525
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.supplement_3.ats600 · Cited by 1,241
Bass, J. B., Farer, L. S., Hopewell, P. C., O'Brien, R., Jacobs, R. F., Ruben, F., Snider, D. E., & Thornton, G. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.149.5.8173779 · Cited by 1,193
A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis
Stover, C. K., Warrener, P., VanDevanter, D. R., Sherman, D. R., Arain, T. M., Langhorne, M. H., Anderson, S. W., Towell, J. A., Yuan, Y., McMurray, D. N., et al. (2000) · Nature · doi:10.1038/35016103 · Cited by 1,034
Streptomycin Treatment of Pulmonary Tuberculosis: A Medical Research Council Investigation
(1948) · BMJ · doi:10.1136/bmj.2.4582.769 · Cited by 986
The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin
Greiner, B., Eichelbaum, M., Fritz, P., Kreichgauer, H.-P., von Richter, O., Zundler, J., & Kroemer, H. K. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6663 · Cited by 917
Yeni, P. G., Hammer, S. M., Carpenter, C. C. J., Cooper, D. A., Fischl, M. A., Gatell, J. M., Gazzard, B. G., Hirsch, M. S., Jacobsen, D. M., Katzenstein, D. A., et al. (2002) · JAMA · doi:10.1001/jama.288.2.222 · Cited by 709
Treatment of 171 Patients with Pulmonary Tuberculosis Resistant to Isoniazid and Rifampin
Goble, M., Iseman, M. D., Madsen, L. A., Waite, D., Ackerson, L., & Horsburgh, C. R. (1993) · New England Journal of Medicine · doi:10.1056/nejm199302253280802 · Cited by 698
Global Trends in Resistance to Antituberculosis Drugs
Espinal, M. A., Laszlo, A., Simonsen, L., Boulahbal, F., Kim, S. J., Reniero, A., Hoffner, S., Rieder, H. L., Binkin, N., Dye, C., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104263441706 · Cited by 671
Exogenous Reinfection as a Cause of Recurrent Tuberculosis after Curative Treatment
van Rie, A., Warren, R., Richardson, M., Victor, T. C., Gie, R. P., Enarson, D. A., Beyers, N., & van Helden, P. D. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910143411602 · Cited by 610
Cited by
Griffith, D. E., Aksamit, T., Brown-Elliott, B. A., Catanzaro, A., Daley, C., Gordin, F., Holland, S. M., Horsburgh, R., Huitt, G., Iademarco, M. F., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200604-571st · Cited by 6,110
Self-citationKornbluth, A., & Sachar, D. B. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.727 · Cited by 2,023
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
Falzon, D., Jaramillo, E., Schünemann, H. J., Arentz, M., Bauer, M., Bayona, J., Blanc, L., Caminero, J. A., Daley, C. L., Duncombe, C., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00073611 · Cited by 1,100
Advances in the development of new tuberculosis drugs and treatment regimens
Zumla, A., Nahid, P., & Cole, S. T. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4001 · Cited by 893
The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis
Diacon, A. H., Pym, A., Grobusch, M., Patientia, R., Rustomjee, R., Page-Shipp, L., Pistorius, C., Krause, R., Bogoshi, M., Churchyard, G., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808427 · Cited by 835
Antituberculosis drug‐induced hepatotoxicity: Concise up‐to‐date review
Tostmann, A., Boeree, M. J., Aarnoutse, R. E., De Lange, W. C. M., Van Der Ven, A. J. A. M., & Dekhuijzen, R. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05207.x · Cited by 781
Spondylodiscitis: update on diagnosis and management
Gouliouris, T., Aliyu, S. H., & Brown, N. M. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq303 · Cited by 780
Frieden, T. R., Sterling, T. R., Munsiff, S. S., Watt, C. J., & Dye, C. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14333-4 · Cited by 689
Intraocular Tuberculosis—An Update
Gupta, V., Gupta, A., & Rao, N. A. (2007) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2007.08.015 · Cited by 680
Dexamethasone for treatment of tuberculous meningitis in adolescents and adults
Tunkel, A. R. (2005) · Current Infectious Disease Reports · doi:10.1007/s11908-005-0059-0 · Cited by 671
Cock, I., Cheesman, M., Ilanko, A., & Blonk, B. (2017) · Pharmacognosy Reviews · doi:10.4103/phrev.phrev_21_17 · Cited by 550
Lucey, M. R., Terrault, N., Ojo, L., Hay, E. J., Neuberger, J., Blumberg, E., & Teperman, L. W. (2013) · Liver Transplantation · doi:10.1002/lt.23566 · Cited by 544
Hepatotoxicity Related to Anti-tuberculosis Drugs: Mechanisms and Management
Ramappa, V., & Aithal, G. P. (2013) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2012.12.001 · Cited by 508
Update on tuberculous pleural effusion
LIGHT, R. W. (2010) · Respirology · doi:10.1111/j.1440-1843.2010.01723.x · Cited by 466
Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline
Nahid, P., Mase, S. R., Migliori, G. B., Sotgiu, G., Bothamley, G. H., Brozek, J. L., Cattamanchi, A., Cegielski, J. P., Chen, L., Daley, C. L., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201909-1874st · Cited by 462
Therapeutic Drug Monitoring in the Treatment of Tuberculosis: An Update
Alsultan, A., & Peloquin, C. A. (2014) · Drugs · doi:10.1007/s40265-014-0222-8 · Cited by 444
Serum Drug Concentrations Predictive of Pulmonary Tuberculosis Outcomes
Pasipanodya, J. G., McIlleron, H., Burger, A., Wash, P. A., Smith, P., & Gumbo, T. (2013) · Journal of Infectious Diseases · doi:10.1093/infdis/jit352 · Cited by 444
SANAI, F. M., & BZEIZI, K. I. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02645.x · Cited by 442
Miliary tuberculosis: new insights into an old disease
Sharma, S. K., Mohan, A., Sharma, A., & Mitra, D. K. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70163-8 · Cited by 438
Bacterial, Fungal, Parasitic, and Viral Myositis
Crum-Cianflone, N. F. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00001-08 · Cited by 422
Pharmacogenetics, Drug-Metabolizing Enzymes, and Clinical Practice
Gardiner, S. J., & Begg, E. J. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.6 · Cited by 406
Meintjes, G., Wilkinson, R. J., Morroni, C., Pepper, D. J., Rebe, K., Rangaka, M. X., Oni, T., & Maartens, G. (2010) · AIDS · doi:10.1097/qad.0b013e32833dfc68 · Cited by 405
Fluoroquinolones, tuberculosis, and resistance
Ginsburg, A. S., Grosset, J. H., & Bishai, W. R. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00671-6 · Cited by 403
Early versus Standard Antiretroviral Therapy for HIV-Infected Adults in Haiti
Severe, P., Jean Juste, M. A., Ambroise, A., Eliacin, L., Marchand, C., Apollon, S., Edwards, A., Bang, H., Nicotera, J., Godfrey, C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0910370 · Cited by 377
Mycobacterium tuberculosis Growth at theCavity Surface: a Microenvironment with FailedImmunity
Kaplan, G., Post, F. A., Moreira, A. L., Wainwright, H., Kreiswirth, B. N., Tanverdi, M., Mathema, B., Ramaswamy, S. V., Walther, G., Steyn, L. M., et al. (2003) · Infection and Immunity · doi:10.1128/iai.71.12.7099-7108.2003 · Cited by 350
Dookie, N., Rambaran, S., Padayatchi, N., Mahomed, S., & Naidoo, K. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx506 · Cited by 346
Childhood Pulmonary Tuberculosis: Old Wisdom and New Challenges
Marais, B. J., Gie, R. P., Schaaf, H. S., Beyers, N., Donald, P. R., & Starke, J. R. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200511-1809so · Cited by 342
Tuberculosis in Pregnant and Postpartum Women: Epidemiology, Management, and Research Gaps
Mathad, J. S., & Gupta, A. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis732 · Cited by 341
International Standards for Tuberculosis Care
Hopewell, P. C., Pai, M., Maher, D., Uplekar, M., & Raviglione, M. C. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70628-4 · Cited by 336
Lortholary, O., Fontanet, A., Mémain, N., Martin, A., Sitbon, K., & Dromer, F. (2005) · AIDS · doi:10.1097/01.aids.0000174450.70874.30 · Cited by 324
Adverse reactions to first-line antituberculosis drugs
Forget, E. J., & Menzies, D. (2006) · Expert Opinion on Drug Safety · doi:10.1517/14740338.5.2.231 · Cited by 315
Gumbo, T., Louie, A., Deziel, M. R., Parsons, L. M., Salfinger, M., & Drusano, G. L. (2004) · The Journal of Infectious Diseases · doi:10.1086/424849 · Cited by 315
Moxifloxacin-containing Regimen Greatly Reduces Time to Culture Conversion in Murine Tuberculosis
Nuermberger, E. L., Yoshimatsu, T., Tyagi, S., O'Brien, R. J., Vernon, A. N., Chaisson, R. E., Bishai, W. R., & Grosset, J. H. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200310-1380oc · Cited by 314
Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosis
Nahid, P., Jarlsberg, L. G., Rudoy, I., de Jong, B. C., Unger, A., Kawamura, L. M., Osmond, D. H., Hopewell, P. C., & Daley, C. L. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-1 · Cited by 305
Diagnosis and treatment of tuberculosis in children
Shingadia, D., & Novelli, V. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00771-0 · Cited by 302
van Well, G. T. J., Paes, B. F., Terwee, C. B., Springer, P., Roord, J. J., Donald, P. R., van Furth, A. M., & Schoeman, J. F. (2009) · Pediatrics · doi:10.1542/peds.2008-1353 · Cited by 295
Moxifloxacin versus Ethambutol in the First 2 Months of Treatment for Pulmonary Tuberculosis
Burman, W. J., Goldberg, S., Johnson, J. L., Muzanye, G., Engle, M., Mosher, A. W., Choudhri, S., Daley, C. L., Munsiff, S. S., Zhao, Z., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200603-360oc · Cited by 286
Pharmacogenetics-based tuberculosis therapy research group, Azuma, J., Ohno, M., Kubota, R., Yokota, S., Nagai, T., Tsuyuguchi, K., Okuda, Y., Takashima, T., Kamimura, S., et al. (2013) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-012-1429-9 · Cited by 278
Mycobacterial diseases and antitumour necrosis factor therapy in USA
Winthrop, K., Baxter, R., Liu, L., Varley, C., Curtis, Jr., Baddley, J., McFarland, B., Austin, D., Radcliffe, L., Suhler, E., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200690 · Cited by 274
(2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2508001 · Cited by 273
Recent progress in the drug development of coumarin derivatives as potent antituberculosis agents
Keri, R. S., B.S., S., Nagaraja, B. M., & Santos, M. A. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.06.017 · Cited by 271
Aminoglycoside Toxicity: Daily versus Thrice-Weekly Dosing for Treatment of Mycobacterial Diseases
Peloquin, C. A., Berning, S. E., Nitta, A. T., Simone, P. M., Goble, M., Huitt, G. A., Iseman, M. D., Cook, J. L., & Curran-Everett, D. (2004) · Clinical Infectious Diseases · doi:10.1086/420742 · Cited by 270
The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement
Bumbacea, D., Arend, S. M., Eyuboglu, F., Fishman, J. A., Goletti, D., Ison, M. G., Jones, C. E., Kampmann, B., Kotton, C. N., Lange, C., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00000712 · Cited by 264
Dorman, S. E., Johnson, J. L., Goldberg, S., Muzanye, G., Padayatchi, N., Bozeman, L., Heilig, C. M., Bernardo, J., Choudhri, S., Grosset, J. H., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200901-0078oc · Cited by 264
History of Antibiotics. From Salvarsan to Cephalosporins
Zaffiri, L., Gardner, J., & Toledo-Pereyra, L. H. (2012) · Journal of Investigative Surgery · doi:10.3109/08941939.2012.664099 · Cited by 260
New Drugs against Tuberculosis: Problems, Progress, and Evaluation of Agents in Clinical Development
van den Boogaard, J., Kibiki, G. S., Kisanga, E. R., Boeree, M. J., & Aarnoutse, R. E. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00749-08 · Cited by 257
Aguado, J. M., Torre‐Cisneros, J., Fortún, J., Benito, N., Meije, Y., Doblas, A., & Muñoz, P. (2009) · Clinical Infectious Diseases · doi:10.1086/597590 · Cited by 257
Impact of Diabetes Mellitus on Treatment Outcomes of Patients with Active Tuberculosis
Dooley, K. E., Tang, T., Golub, J. E., Dorman, S. E., & Cronin, W. (2009) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2009.80.634 · Cited by 256
Antituberculosis drugs and hepatotoxicity
YEW, W. W., & LEUNG, C. C. (2006) · Respirology · doi:10.1111/j.1440-1843.2006.00941.x · Cited by 256
Pulmonary drug delivery systems for tuberculosis treatment
Pham, D.-D., Fattal, E., & Tsapis, N. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.12.009 · Cited by 185
Pachi, A., Bratis, D., Moussas, G., & Tselebis, A. (2013) · Tuberculosis Research and Treatment · doi:10.1155/2013/489865 · Cited by 185
Peripheral Tuberculous Lymphadenitis: Epidemiology, Diagnosis, Treatment, and Outcome
Polesky, A., Grove, W., & Bhatia, G. (2005) · Medicine · doi:10.1097/01.md.0000189090.52626.7a · Cited by 165
Mycobacterial infections in solid organ transplant recipients
Meije, Y., Piersimoni, C., Torre-Cisneros, J., Dilektasli, A. G., & Aguado, J. M. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12641 · Cited by 124
Paradoxical responses in non-HIV-infected patients with peripheral lymph node tuberculosis
Cho, O.-H., Park, K.-H., Kim, T., Song, E. H., Jang, E.-Y., Lee, E. J., Chong, Y. P., Choi, S.-H., Lee, S.-O., Woo, J. H., et al. (2009) · Journal of Infection · doi:10.1016/j.jinf.2009.05.006 · Cited by 87
Hepatotoxicity from antituberculous therapy in the elderly: a systematic review
Hosford, J. D., von Fricken, M. E., Lauzardo, M., Chang, M., Dai, Y., Lyon, J. A., Shuster, J., & Fennelly, K. P. (2015) · Tuberculosis · doi:10.1016/j.tube.2014.10.006 · Cited by 63
Salcedo, J., Rosales, M., Kim, J. S., Nuno, D., Suen, S.-C., & Chang, A. H. (2021) · PLOS ONE · doi:10.1371/journal.pone.0254950 · Cited by 41
Wei, Y.-F., Liaw, Y.-S., Ku, S.-C., Chang, Y.-L., & Yang, P.-C. (2008) · Journal of the Formosan Medical Association · doi:10.1016/s0929-6646(08)60140-0 · Cited by 32
Post-therapy paradoxical response in immunocompetent patients with lymph node tuberculosis
Park, K.-H., Cho, O.-H., Chong, Y. P., Lee, S.-O., Choi, S.-H., Jeong, J.-Y., Kim, M.-N., Kim, Y. S., Woo, J. H., & Kim, S.-H. (2010) · Journal of Infection · doi:10.1016/j.jinf.2010.08.011 · Cited by 18
Metadata
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-02-15
- Volume
- 167
- Issue
- 4
- Pages
- 603-662
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2418210342
- Cited by
- 1,944
- References
- 251
- FWCI
- 59.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.